Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 8/20 | 0.52 |
| ▸ | CTSS | P25774 | 6/20 | 0.49 |
| ▸ | CTSV | O60911 | 4/20 | 0.49 |
| ▸ | CTSL | P07711 | 3/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | CCR1 | P32246 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4206106 | 1.00 | CTSK (0.52) | CTSKCTSSCTSVCTSLMGLL | |
| SCHEMBL4201896 | 0.77 | CTSK (0.59) | CTSKCTSS | |
| SCHEMBL4207288 | 0.77 | CTSK (0.59) | CTSKCTSS | |
| SCHEMBL4201901 | 0.77 | CTSK (0.59) | CTSKCTSS | |
| SCHEMBL13677296 | 0.77 | CTSK (0.52) | CTSKCTSSCTSVCTSL | |
| SCHEMBL7148306 | 0.77 | CTSK (0.52) | CTSKCTSSCTSVCTSL | |
| SCHEMBL4451293 | 0.77 | CTSK (0.52) | CTSKCTSSCTSVCTSL | |
| SCHEMBL6808367 | 0.76 | CTSK (0.80) | CTSKCTSSCTSVCTSLCCR1 | |
| SCHEMBL13677133 | 0.76 | CTSK (0.51) | CTSKCTSSCTSVCTSL | |
| SCHEMBL12828388 | 0.76 | CTSK (0.80) | CTSKCTSSCTSVCTSLCCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131502-A1 | Biologically active compounds | QUIBELL MARTIN | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131502-A1 | Biologically active compounds | COLGALT1, SOST, COL1A1 | CTSK 116/4885CTSS 52/4885CTSV 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.